Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

PHYTOLOOP – In Vitro Platform To Produce High-Value APIs From Endangered Endemic Plants

Objetivo

PHYTOLOOP is a deep-tech biomanufacturing project by Kanara (Vulkania Labs S.L.) that enables the sustainable, traceable and scalable production of high-value plant-derived Active Pharmaceutical Ingredients (APIs) from endangered and endemic species, starting with the Canary Islands’ unique flora. The project replaces destructive wild harvesting and inefficient agricultural extraction with a modular, AI-assisted in-vitro platform that cultivates plant cells in closed bioreactors under fully controlled, sterile conditions.

The approach integrates AI-driven optimisation, advanced plant biotechnology and automated bioreactors to drastically reduce trial-and-error in media formulation and process control, achieving ≥50 % fewer optimisation cycles, ≥20 % lower production cost and reproducible yields with <10 % batch variability. By maintaining elite, high-yielding cell lines ex-situ, the system ensures perpetual access to valuable APIs while conserving biodiversity.

Over 24 months, PHYTOLOOP will evolve from TRL 4 to TRL 6, delivering a validated 50 L automated pilot line and a regulatory-ready platform for pharmaceutical adoption. The project includes four technical and business objectives:

1. Establish stable in-vitro cell lines from at least three endangered endemic species;
2. Integrate and automate the full pilot-scale bioprocess;
3. Validate market demand through Letters of Intent and an investor-ready data room;
4. Define GMP and industrialisation roadmaps for post-project pilots.

Backed by confirmed LOIs from pharma and institutional partners (Adventia Pharma, MOEVE, CSIC, ICIA) and co-funded 30 % by Kanara, PHYTOLOOP anchors a new biodiversity-based bio-industry in the Canary Islands, strengthening EU strategic autonomy in APIs while creating a replicable, nature-positive model of industrial biotechnology.

Ámbito científico (EuroSciVoc)

Este proyecto aún no se ha clasificado con EuroSciVoc.
Sugiera los ámbitos científicos que considere más relevantes y ayúdenos a mejorar nuestro servicio de clasificación.

Palabras clave

Programa(s)

Tema(s)

Régimen de financiación

HORIZON-CSA - HORIZON Coordination and Support Actions

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) HORIZON-WIDERA-2025-02

Ver todos los proyectos financiados en el marco de esta convocatoria

Coordinador

VULKANIA LABS SL
Aportación neta de la UEn
€ 499 476,95
Dirección
LA CUESTA 17 LA CUESTA DE LA VILLA
38390 SANTA URSULA SANTA CRUZ DE TENERIFE
España
Pyme
Sí
Región
Canarias Canarias Tenerife
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
Sin datos